![Rainer Fischer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Rainer Fischer
Director/Board Member at Indiana Biosciences Research Institute
Rainer Fischer active positions
Companies | Position | Start | End |
---|---|---|---|
Indiana Biosciences Research Institute
![]() Indiana Biosciences Research Institute Miscellaneous Commercial ServicesCommercial Services The Indiana Biosciences Research Institute is a biomedical research organization that aims to solve challenging health problems and improve patient outcomes. The Eli Lilly and Company Diabetes Center of Excellence, located at the institute, is dedicated to studying the molecular basis of diabetes and its complications. The non-profit company is based in Indianapolis, IN. The company's research focuses on translating disease hypotheses into potential therapies. Alan Palkowitz has been the CEO of the company since 2020. | Director/Board Member | - | - |
Corporate Officer/Principal | 2019-04-18 | - | |
Chief Executive Officer | 2017-09-30 | 2019-04-18 | |
Chief Tech/Sci/R&D Officer | 2016-09-30 | 2019-04-18 |
Career history of Rainer Fischer
Statistics
International
United States | 2 |
Operational
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectoral
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Indiana Biosciences Research Institute
![]() Indiana Biosciences Research Institute Miscellaneous Commercial ServicesCommercial Services The Indiana Biosciences Research Institute is a biomedical research organization that aims to solve challenging health problems and improve patient outcomes. The Eli Lilly and Company Diabetes Center of Excellence, located at the institute, is dedicated to studying the molecular basis of diabetes and its complications. The non-profit company is based in Indianapolis, IN. The company's research focuses on translating disease hypotheses into potential therapies. Alan Palkowitz has been the CEO of the company since 2020. | Commercial Services |
- Stock Market
- Insiders
- Rainer Fischer
- Experience